Eupraxia Pharmaceuticals Reports Fourth Quarter and 2023 Financial Results — Comtex05:01 PM ET 04/01/2024 VICTORIA, BC, April 1, 2024 /PRNewswire via COMTEX News Network/ -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company leveraging its... |
Canadian Investment Regulatory Organization Trade Resumption - EPRX — Comtex09:40 AM ET 03/12/2024 TORONTO, March 12, 2024 /PRNewswire via COMTEX News Network/ -- Trading resumes in: |
Canadian Investment Regulatory Organization Trade Resumption - EPRX — Comtex09:39 AM ET 03/12/2024 TORONTO, Mar 12, 2024 (CNW Group via COMTEX News Network) -- Trading resumes in: |
Canadian Investment Regulatory Organization Trading Halt - EPRX — Comtex04:05 PM ET 03/11/2024 TORONTO, March 11, 2024 /PRNewswire via COMTEX News Network/ -- The following issues have been halted by CIRO: |